No Data
No Data
Express News | 'DEA Appears To Question Marijuana's Medical Value Despite Rescheduling Recommendation' - Marijuana Moment
FSD Pharma Advances MS Treatment Trials
Newsweek Reporter Kevin Sabet Says On X "I Can Now Say With Full Confidence That The Administrator Of DEA, Anne Milgram, Did Not Sign The Rescheduling Order, Breaking With Five Decades Of Precedent And Established Law And Regulations (Two Confidential...
Newsweek Reporter Kevin Sabet Says On X "I Can Now Say With Full Confidence That The Administrator Of DEA, Anne Milgram, Did Not Sign The Rescheduling Order, Breaking With Five Decades Of Precedent An
Express News | 'Declassifying Cannabis Still Leaves Pot Stocks In Limbo' - Wall Street Journal
FSD Pharma Trials Supplement for Alcohol Intoxication
DEA Moving To Reclassify Marijuana As Less Dangerous Drug
DEA Moving To Reclassify Marijuana As Less Dangerous Drug